ANALYST RECOMMENDATIONS : Biogen, Colgate, Comcast, Glencore, Sage...
Every day, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information is used to shed light on the movements of certain stocks or the market sentiment on a company.
- Air Products: Goldman Sachs reinstated coverage with a recommendation of buy. PT up 29% from last price to $295.
- Axalta: Goldman Sachs reinstated coverage with a recommendation of buy. PT up 36% to $29.
- Biogen: Stifel raised its recommendation to buy from hold. PT up 18% to $299.
- Colgate-Palmolive: J.P. Morgan upgrades to overweight from neutral. PT up 14% to $79.
- Comcast: Citi analyst upgrades to buy from neutral. PT up 25% to $36.
- DS Smith: Morgan Stanley moves from Overweight to Equal-Weight with a GBp 340 target.
- Eastman Chemical: Goldman Sachs reinstated coverage with a recommendation of neutral. PT set to $78.
- Glencore: Goldman Sachs remains Buy with a price target raised from GBp 610 to GBp 700.
- Huntsman: Goldman Sachs reinstated coverage with a recommendation of sell. PT up 1.5% to $26.
- Informa: Goldman Sachs resumes coverage to buy targeting GBp 775.
- Kronos: Goldman Sachs initiated coverage with a recommendation of sell. PT up 1.5% to $9.
- Mondi: Morgan Stanley moves from Equal-Weight to Overweight targeting GBp 1800.
- Owens & Minor: Citi downgrades to neutral from buy. PT up 19% to $18.
- Sage: HSBC starts tracking as buy, targeting GBp 845.
- Simon Property: Morgan Stanley reinstated coverage with a recommendation of overweight. PT up 40% to $131.
- Staar Surgical: Mizuho Securities initiated coverage with a recommendation of buy. PT up 21% to $85.
- Smurfit Kappa: Morgan Stanley moves from Equal-Weight to Overweight, targeting GBp 3,200.
- Willis Towers: Piper Sandler upgrades to overweight from neutral. PT up 24% to $250.
By 
